FibrinogenAEK does not support rapid clearance of S aureus bacteria following acute peritoneal infection but retains some capacity to limit host lethality. The number of S aureus CFUs present in peritoneal lavage fluid collected 1 hour after intraperitoneal infection with (A) 0.8 × 109 CFUs strain USA300 S aureus and (B) 1 × 109 CFUs strain Newman S aureus from WT, FibAEK, Fib+/−, and Fib−/− mice (n = 6 per genotype). Data are presented as mean ± standard error of the mean with statistical comparisons made by Student t test. (C) Flow cytometric analysis of myeloid cell populations harvested from the peritoneal cavity of WT and FibAEK mice (n = 6 mice per genotype). Analyses are presented as the mean ± standard error of the mean. (D) Representative photomicrographs of cytospin preparations of peritoneal lavage fluid taken 1 hour after intraperitoneal infection with 1 × 109 CFUs S aureus. Note the cell-associated and free bacteria in samples from FibAEK and Fib−/− mice that are largely absent in samples from WT and Fib+/− mice. Scale bar, 20 μm. (E) Analysis of fibrinogen-dependent bacterial clumping with suspensions of strain Newman S aureus with and without expression of clumping factor A (ClfA). Notably, both WT and fibrinogenAEK support bacterial clumping at a concentration of 2 μg/mL and above. (F) Analyses of coagulase (Coa)-induced plasma clotting with citrate-plasma preparations from WT, homozygous FibAEK, and Fib−/− mice using supernatants prepared from stationary phase cultures of both strain Newman WT (Coa+) S aureus and Coa-negative (Coa−) strain Newman S aureus. Survival analyses of WT, FibAEK, and Fib−/− mice (n = 12 per genotype) following intraperitoneal infection with (G) 0.4 × 109 CFUs or (H) 1 × 109 CFUs strain Newman S aureus. *P < .01 for WT compared with Fib−/− or FibAEK; **P < .01 for FibAEK compared with Fib−/− using Kaplan-Meier log-rank analysis.